Literature DB >> 1688583

Natural antibodies to IFN-gamma in man and their increase during viral infection.

A Caruso1, C Bonfanti, D Colombrita, M De Francesco, C De Rango, I Foresti, F Gargiulo, R Gonzales, G Gribaudo, S Landolfo.   

Abstract

Natural antibodies to IFN-gamma were found in healthy individuals ranging from newborn babies to adults and, at higher levels, in patients suffering from different viral infections. During a viral infection, the titer of anti-IFN-gamma antibodies was observed to be correlated with the stage of the disease. Antibodies specific to IFN-gamma were affinity purified both from sera taken from healthy individuals and sera from viral-infected patients, by using a rIFN-gamma-coupled CNBr-activated Sepharose 4B column. The antibodies were found to be of the IgG class, and maintained their ability to bind rIFN-gamma. They were then tested for neutralizing activity and none of the IgG preparations we analyzed impaired the antiviral activity of rIFN-gamma. This finding suggests that the antigenic determinants recognized by these antibodies on the IFN-gamma molecule are located outside the site, on the IFN-gamma molecule, responsible for its antiviral activity.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1688583

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  16 in total

Review 1.  Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases.

Authors:  D R Lucey; M Clerici; G M Shearer
Journal:  Clin Microbiol Rev       Date:  1996-10       Impact factor: 26.132

2.  Spontaneously occurring neutralizing antibodies against granulocyte-macrophage colony-stimulating factor in patients with autoimmune disease.

Authors:  A Meager; M Wadhwa; C Bird; P Dilger; R Thorpe; J Newsom-Davis; N Willcox
Journal:  Immunology       Date:  1999-07       Impact factor: 7.397

3.  Alpha interferon (2b) in combination with zidovudine for the treatment of presymptomatic feline leukemia virus-induced immunodeficiency syndrome.

Authors:  N S Zeidner; M H Myles; C K Mathiason-DuBard; M J Dreitz; J I Mullins; E A Hoover
Journal:  Antimicrob Agents Chemother       Date:  1990-09       Impact factor: 5.191

4.  Detection of autoantibodies to cytokines.

Authors:  K Bendtzen; M B Hansen; C Ross; M Svenson
Journal:  Mol Biotechnol       Date:  2000-03       Impact factor: 2.695

5.  A novel strategy for generating monoclonal antibodies from single, isolated lymphocytes producing antibodies of defined specificities.

Authors:  J S Babcook; K B Leslie; O A Olsen; R A Salmon; J W Schrader
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-23       Impact factor: 11.205

6.  Autoantibodies against granulocyte-macrophage colony stimulating factor and interleukin-3 are rare in patients with Felty's syndrome.

Authors:  B Hellmich; A Ciaglo; H Schatz; G Coakley
Journal:  Ann Rheum Dis       Date:  2004-07       Impact factor: 19.103

7.  Absence of circulating interferon in patients with inflammatory bowel disease. Suggestion against an autoimmune etiology.

Authors:  M R Capobianchi; S Fais; M C Di Paolo; D Agostini; P Paoluzi; F Pallone; F Dianzani
Journal:  Clin Exp Immunol       Date:  1992-10       Impact factor: 4.330

8.  Naturally occurring anti-interferon-alpha 2a antibodies in patients with acute viral hepatitis.

Authors:  Y Ikeda; G Toda; N Hashimoto; N Umeda; K Miyake; M Yamanaka; K Kurokowa
Journal:  Clin Exp Immunol       Date:  1991-07       Impact factor: 4.330

9.  Binding of cytokines to pharmaceutically prepared human immunoglobulin.

Authors:  M Svenson; M B Hansen; K Bendtzen
Journal:  J Clin Invest       Date:  1993-11       Impact factor: 14.808

10.  Anti-IL-1 alpha autoantibodies in patients with rheumatic diseases and in healthy subjects.

Authors:  H Suzuki; T Ayabe; J Kamimura; H Kashiwagi
Journal:  Clin Exp Immunol       Date:  1991-09       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.